Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: ASE
  • Sector: Materials
  • Industry: Chemicals
  • Sub-Industry: Agricultural Chemicals

Actinogen Ltd

+ Add to Watchlist

ACW:AU

0.0790 AUD 0.00000.00%

As of 02:10:27 ET on 05/29/2015.

Snapshot for Actinogen Ltd (ACW)

Open: 0.0780 Day's Range: 0.0740 - 0.0790 Volume: 500,416
Previous Close: 0.0790 52wk Range: 0.0110 - 0.1500 1-Yr Rtn: -

Stock Chart for ACW

No chart data available.
  • ACW:AU 0.0790
  • 1D
  • 1M
  • 1Y
0.0790
Interactive ACW Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACW

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -0.0067
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 47.89
Shares Outstanding (M) 606.16
30 Day Average Volume 2,192,017
Price/Book (mrq) 4.6606
Price/Sale (ttm) 1,213.5111
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACW

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for ACW

Actinogen Limited is a biotechnology company that engages in the commercialization of bioactive compounds. The Company is developing a novel drug to treat the condition and other age-related neurodegenerative diseases. Actinogen was previously focused on antimicrobial and anti-cancer early stage drug discovery.

Bill KetelbeyManaging Director/CEOVincent RufflesVP:Clinical Research
Peter Gordon WebseSecretary
More Company Profile & Key Executives for ACW

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil